Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety and Tolerability of MA09-hRPE Cells in Patients With Stargardt's Macular Dystrophy(SMD)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2012 by CHA Bio & Diostech.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
CHA Bio & Diostech
ClinicalTrials.gov Identifier:
NCT01625559
First received: June 18, 2012
Last updated: October 22, 2012
Last verified: August 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2014
  Estimated Primary Completion Date: August 2014 (Final data collection date for primary outcome measure)